7JS.F Diagnostyka S.A.

Healthcare Diagnostics & Research Frankfurt Exchange
34.08 EUR
Close of Nov 11, 2026
32.14 46.95
Market cap
EUR 1.15B
P/E
19.1x
P/B
9.78x
ROE
54.9%
Dividend yield
3.08%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 7JS.F undervalued?

Graham number
Price34.08
Graham value11.81
Premium188.5%

7JS.F trades 188.5% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Diagnostyka S.A. fundamental analysis

No fundamental analysis for Diagnostyka S.A. yet.

Diagnostyka S.A. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Diagnostyka S.A.

Diagnostyka S.A. provides diagnostic services in Poland. The company operates as a medical laboratory, which offers services, such as ultrasound, X-ray, computed tomography, and magnetic resonance imaging. It also offers specialized research in the field of microbiology, autoimmunity, toxicology, and molecular biology, as well as human genome research, histopathological examinations, immunohistochemical tests, cytological tests, and cytogenetic tests. The company provides se…

Full company profile